Weekly Industry News - Anti-Corruption / FCPA & International Trade

Anti-Corruption/ FCPA and International Trade – the FCPA considerations in M&A transactions, China’s anti-corruption crackdown closes in on GlaxoSmithKline Exec for bribery and more.

United States: FCPA Considerations In M&A Transactions by Jay Holtmeier, Kimberley A. Parker, Lillian Howard Potter, Erin G.H. Sloane, Emily Stark and Roger M. Witten Published on mondaq

Below is an excerpt from WilmerHale’s 2014 M&A Report, which was released on May 6, 2014. This excerpt summarizes the FCPA risks for purchasers and sellers in M&A transactions and suggests affirmative steps companies can take to manage those risks both pre- and post-closing. View the full report or request a hard copy… [ Read More ]

NY Judge Blasts Ex-Magyar Execs’ Silence In FCPA Case by Max Stendahl Published on Law 360

A New York judge on Wednesday criticized attorneys for three former Magyar Telekom PLC executives for advising the defendants not to answer most questions during depositions in a Foreign Corrupt Practices Act case brought by the U.S. Securities and Exchange Commission, calling the move “obstructionist.”… [ Read More ]

China’s Anti-Corruption Crackdown Closes In On GlaxoSmithKline Exec For Bribery And Price Surges by by Michelle FlorCruz Published on International Business Times

Chinese President Xi Jinping’s widening crackdown on corruption, which snared a GlaxoSmithKline (LON:GSK) executive on Wednesday, is yet another sign that foreign companies’ biggest risk in the country may be insisting on high prices for their products… [ Read More ]